Skip to main content
. 2017 Nov 3;17:101. doi: 10.1186/s12935-017-0472-0

Fig. 1.

Fig. 1

CSCs cause cancer relapse and resistance after conventional cancer therapy. The conventional therapy targeting the tumor bulk without targeting the CSCs leads to tumor recurrence